Close Menu

FierceBiotech's Ryan McBride and John Carroll received more than 130 nominations for their 2011 Women in Biotech feature. "True to our mission of providing readers the top news in biotech, many of the honorees here are women who drove some of the big stories we covered this year," they write. These women are "rallying scientists at young startups, gearing up for important late-stage trials or leading research of serious health concerns such as HIV," among other endeavors, McBride and Carroll add.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The UK and the European Union have come to a sticking point in the negotiation of how the UK might remain involved in the Horizon Europe research program, the Guardian reports.

The New York Times reports that experts pushed during a meeting of an FDA advisory board for the agency to require more safety data from SARS-CoV-2 vaccine trials.

The Washington Post reports Moderna expects that it will have enough data on its candidate SARS-CoV-2 vaccine to submit to regulatory authorities by mid-November.

In Science this week: ANXA11 variants affect calcium homeostasis and stress granule disassembly in ALS, and more.